Nobody has been filling niches as aggressively as GE Medical Systems. Last month, the company acquired electron-beam tomography pioneer Imatron, swapping each share of Imatron
Nobody has been filling niches as aggressively as GE Medical Systems. Last month, the company acquired electron-beam tomography pioneer Imatron, swapping each share of Imatron common stock for 0.051 shares of GE common stock (a ratio we misreported as 1:5 in the Jan. 9 issue). GE is ready to go again, having signed a definitive agreement to acquire the assets of MedicaLogic, a provider of electronic medical record (EMR) systems for outpatients. This time GE is paying cash: $20 million. The company plans to couple MedicaLogic's EMR products with its new Centricity Clinical Information System, thereby providing a comprehensive, end-to-end medical information product that links hospitals, clinics, and physician offices. Incorporating MedicaLogic's installed base is an important first step. Its products are in hundreds of hospitals and affiliated doctors' offices in the U.S. where they are used by more than 16,000 physicians, according to GE.
Centricity is being showcased as a premier component of the Indiana Heart Hospital, a $60 million, 210,000-square-foot facility now being constructed in Indianapolis. The hospital, which is due to open December 2002, will utilize Centricity to capture, route, and present EMR. The system will promote a paperless, filmless, and wireless environment, eliminating medical record storage rooms, paper charting areas, and central nursing stations.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.
Emerging MRI Scoring System May Help Predict Recurrent and Metastatic Hepatocellular Carcinoma
February 12th 2025Preoperative use of the scoring system for gadoxetic acid-enhanced MRI demonstrated an average AUC of 85 percent and average specificity of 89 percent in external validation cohorts for pathologic features of hepatocellular carcinoma.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.